“Bringing the world into focus
through the lens of Scripture”

 

frosty@khouseafrica.com

 

 

 

K-House Africa

 

Banking Details

 

 

 

 Watch us
on You Tube

 

Radio 66/40

 

 

 

 Africa news

 

THE STRUGGLE FOR JERUSALEM

 

 

The Rise Of Islam

 

 

THE DECLINE OF THE USA

 

 

GLOBAL RELIGION

 

 

GLOBAL PESTILENCE

 

 

Global Government

 

 

THE RISE OF THE FAR EAST

 

 

THE RISE OF THE EUROPEAN SUPER STATE

 

 

WEAPONS PROLIFERATION

 

 

THE MAGOG INVASION

 

 

Classics

 

 

UNDERSTAND THE TIMES

 

 

 

Articles

 

DVD PRICELIST

 

Price List

 

 Kings High Way Briefing Packs

 

Topical Teachings

DVD Briefing Back

Packs

 

Audio CD

 

Audio MP3 Collections

 

DVD

 Commentaries

 

Strategic Trends

 

Verse By Verse Commentaries

 

Old Testament Study Notes

 

New Testament Study Notes

 

Personal Update

 

Donations

 

New Product Notice

 

FAQ

 

Contact US

 

K-House USA

 

Comment Line

 

Time Traveller

 

Other Links

 

DEVOTIONAL

 

Words in Red

 

Prophecy News Watch

 

The Coming Prince

 

THE WITNESS 1 Audio MP3

 

THE WITNESS 2 Audio MP3

 

hawk warrior

 

 

 

 

 

 

INTERNATIONAL NEWS FEEDS


 In The News provided by Koinonia House


Best viewed with Internet Explorer.


 

Monitor The Strategic Trends

Biotech & Global Pestilence Introduction:

 

The threat of germ warfare has brought to the forefront long-forgotten diseases like plague, anthrax, and smallpox. Recent television news programs have highlighted secret projects in the former Soviet Union to develop antibiotic-resistant strains of genetically engineered viruses and bacteria.


[READ THE FULL INTRODUCTION]

 

 


 

Human Nature

Speakers:

Ron Matsen

R179.00

 

 

 

About available formats

Description: 

What does it mean to be human? Philosophers, theologians, sociologists and psychologists have attempted to understand the nature of mankind for ages. Their conclusions often contradict each other which lead to confusion rather than clarification. Clearly Man is a very complicated social being. The Bible tells us that man is “fearfully and wonderfully made.”
  • How do we understand our makeup and does it make a difference?
  • What is the meaning of being “created in the image of God?”
  • What causes our natural responses and can we change this behaviour?

Join Ron Matsen from the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of our “Human Nature” and gives insight into the architecture and accountability of all mankind.

This briefing pack contains approx. 2 hours of teaching.

  • DVD discs
  • M4A files
  • PDF Notes file
  •  

CANCER  Awareness

 

 

Dedicated Page

 

 

 

Price R 179

 

 

***Brand New Release***

 

Beginning of Wisdom

by

 Dr. Chuck Missler

“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.

 


 

 

Price R 179.00

 

 

The Gospel: The Message of Reconciliation

DVD

by Ron Matsen 

 

 

 

Price R 179.00

 

 

 

Description

One of the last instructions given by Jesus to the Church was, “Go into all the world and preach the gospel.” (Mark 16:15)

The fact is most Christians don’t know how to share their faith effectively. Sadly, many of the people they know in the world today are wandering around, lost and without hope, having never heard the wonderful Message of Reconciliation.

How would you answer the question, “What must I do to be saved?”

What are the essential facts, demands and promises of the Gospel?

Why are we told to evangelize?

Join Ron Matsen in the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of “The Gospel – The Message of Reconciliation” and gives practical insight into how to share the essential doctrines of salvation.

This briefing pack contains 2 hours of teaching

© Copyright 2013

Available in the following formats

DVD:

  • 1 Disc

  • 2 M4A Files

  • 1 PDF Notes File

  • Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  (This DVD will be viewable in other countries WITH the proper DVD player and television set.)

 

Earth News, Earth Science, Energy Technology, Environment News

 

NEW DEDICATED PAGE

 

 

Cher-Bang Bang (My Baby Shot Me Down) 1966 Music Video.avi

 

SABC NewsSABC Logo

 

I WILL CURSE THOSE WHO

 

 CURSE THEE'

 

 

THE PERFECT STORM

 
Diseases/Conditions News Headlines - Yahoo! News

 

 

Study shows Novo's new diabetes drug effective and safe for children

 
‎16 ‎September ‎2014, ‏‎12:01:44 PMGo to full article
COPENHAGEN (Reuters) - Novo Nordisk's new long-acting insulin Tresiba has been shown to be effective and safe for long-term use in children and young adults with type 1 diabetes, according to new data from a late-stage trial presented on Tuesday. Long-acting Tresiba is an important product for future growth at the company, which is the world's top insulin maker. U.S. regulators have refused to approve Tresiba due to potential heart risks, dealing a blow to the company. Tresiba was approved in the European Union last year. ...
 

AstraZeneca gets up to $500 million from Lilly for Alzheimer's drug

 
‎16 ‎September ‎2014, ‏‎09:17:42 AMGo to full article
A man walks past a sign at an AstraZeneca site in MacclesfieldBy Ben Hirschler LONDON (Reuters) - AstraZeneca has signed a partnership deal with U.S. rival Eli Lilly that could earn the British company up to $500 million if a promising – but risky – experimental Alzheimer’s drug proves successful. AstraZeneca said in May that it was looking to find a partner for its so-called BACE inhibitor drug called AZD3293, which is set to enter late-stage Phase III clinical testing against Alzheimer's. The decision by Lilly to buy into the project is an endorsement of the science behind the new oral drug, given the U.S. ...
 
 

NY attorney general sues Actavis and Forest Labs over Alzheimer's drug

 
‎16 ‎September ‎2014, ‏‎03:29:44 AMGo to full article
By Devika Krishna Kumar (Reuters) - The attorney general of New York filed a lawsuit against Actavis Plc and its subsidiary to stop the companies from discontinuing its Alzheimer's drug, alleging that they were trying to maintain a monopoly position illegally. Eric Schneiderman, New York's attorney general, alleges that Actavis and its subsidiary Forest Laboratories violated anti-trust and state laws. “Unfortunately, schemes to block competition, without considering the consequences to patients, are a growing trend in the health care industry. ...
 

APNewsBreak: NY bid to halt Alzheimer's drug swap

 
‎16 ‎September ‎2014, ‏‎01:11:03 AMGo to full article
ALBANY, N.Y. (AP) — New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year.
 

Pre-diabetes, diabetes rates fuel national health crisis

 
‎15 ‎September ‎2014, ‏‎11:07:18 PMGo to full article
Nearly half of adults have either pre-diabetes or diabetes, raising their risk of heart attacks, blindness, amputations and cancer.
 

Epirus, Ranbaxy win India approval for arthritis drug copy

 
‎15 ‎September ‎2014, ‏‎10:10:50 PMGo to full article
A Ranbaxy office building is pictured in the northern Indian city of MohaliBy Natalie Grover and Zeba Siddiqui (Reuters) - Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd, will sell a copycat version of Johnson & Johnson's and Merck & Co Inc's infliximab, an anti-inflammatory drug with annual sales of about $6 billion. ...
 
 

Judith Light Is Taking the Flu Very Seriously

 
‎15 ‎September ‎2014, ‏‎10:09:51 PMGo to full article
Judith Light Is Taking the Flu Very SeriouslyIn the most loving and ironic twist of fate, actress Judith Light has gone from being a woman of the night in One Life To Live to one of the madams in Dallas in a very upscale, very southern house of ill repute. She also got to stare at Tony Danza's cute butt for several seasons on Who's The Boss... Not a bad career if you ask me, and one of...
 
 

Black lung disease surges to highs not seen since the '70s, research shows

 
‎15 ‎September ‎2014, ‏‎07:12:27 PMGo to full article
The likely culprit: a failure by coal mining companies to use readily available tools to control the dust that lodges in miners' lungs.
 

Breast Cancer Screenings In Older Women May Lead To Over-Diagnosis, Study Says

 
‎15 ‎September ‎2014, ‏‎06:01:29 PMGo to full article
Breast Cancer Screenings In Older Women May Lead To Over-Diagnosis, Study SaysWhile regular screenings can be useful in early detection of breast cancer, age should be considered when weighing the benefits. The United States Preventive Services Task Force currently recommends women between ages 50 and 74 go in for mammograms every other year, but a new study says that, for women over 70, there may not be much of a...
 
 

Avanir's drug reduces Alzheimer's related agitation in trial

 
‎15 ‎September ‎2014, ‏‎03:51:49 PMGo to full article
(Reuters) - Avanir Pharmaceuticals Inc said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo, sending the company's shares up 55 percent to an over eight-year high. The company said based on the mid-stage trial data it planned to request a meeting with both the U.S. Food and Drug Administration and the European Medicines Agency. Alzheimer's is the most common form of dementia and is a progressive neurodegenerative disease, which eventually leads to death. ...
 

Disease threatens as Kashmir flood waters turn fetid

 
‎15 ‎September ‎2014, ‏‎03:46:19 PMGo to full article
Kashmiri men pass a damaged house as they wade through a flooded street in SrinagarBy Fayaz Bukhari SRINAGAR (Reuters) - Indian emergency workers on Monday battled to prevent waterborne diseases like cholera from spreading as fetid water swilled around the Kashmir valley more than a week after the worst flooding in more than a century. More than 75,000 people were still in partly submerged homes in Srinagar, Kashmir's main city of more than a million people, where roads have been transformed into stagnant canals strewn with wreckage, trash and dead animals. "Floating carcasses have become a big source of worry with most houses still waterlogged. ...
 
 

Stints of standing while working may reduce back pain

 
‎12 ‎September ‎2014, ‏‎07:38:29 PMGo to full article
Australian office workers alternated between sitting and standing every 30 minutes for a week and felt less fatigued and less back pain and lower-leg pain than when they stayed seated the whole day. “Our results confirm what we expected - that introducing regular breaks across the workday leads to improvements in fatigue and musculoskeletal symptoms compared to sitting all day,” said Alica A. Thorp, a postdoctoral research fellow at the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, who led the study. Prolonged sitting has been linked with a variety of health problems, but office workers often have little choice about their work environment. Past research has found office workers spend about 75 percent of their work day sitting in a chair, Thorp's team writes in Occupational and Environmental Medicine.
 

Lilly stomach cancer drug prolongs life in colon cancer study

 
‎12 ‎September ‎2014, ‏‎04:55:48 PMGo to full article
By Ransdell Pierson (Reuters) - Eli Lilly and Co's LLY.N Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday. Based on favorable data from the Phase III study, Lilly said it would ask regulators in the first half of 2015 to approve Cyramza in patients with colorectal cancer that has spread to other parts of the body. It plans to present detailed results from the trial at a scientific meeting next year. ...
 

Merck KGaA ends lung cancer vaccine trials

 
‎12 ‎September ‎2014, ‏‎02:16:51 PMGo to full article
FRANKFURT (Reuters) - German drugmaker Merck KGaA drug stopped all remaining clinical studies of the experimental lung cancer vaccine tecemotide, formerly known as Stimuvax, after renewed attempts to show its effectiveness failed. The drug - licensed from U.S. biotech firm Oncothyreon - was being be tested on patients with Stage III non-small cell lung cancer (NSCLC), but disappointing results of a trial in Japan prompted the company to stop all other studies involving tecemotide, it said on Friday. ...
 

JP Morgan's Dimon finishes scheduled cancer treatments: WSJ

 
‎11 ‎September ‎2014, ‏‎08:23:32 PMGo to full article
JPMorgan Chairman and CEO Jamie Dimon speaks at the Aspen Institute's "Closing the Workforce Skills Gap" seminar(Reuters) - JPMorgan Chase & Co CEO Jamie Dimon, who was diagnosed with throat cancer this year, finished his scheduled rounds of radiation and chemotherapy treatment this week, the Wall Street Journal said, citing people familiar with the matter. Doctors will monitor Dimon, who started treatment about eight weeks ago, to determine if he is cancer-free, the Journal reported. Dimon is expected to host the company's third quarter earnings call next month, when he also plans to resume international travel and client meetings, the Journal said. "I took naps when I had to, went home early, and there were days when I was in treatment all day long," Dimon told the Journal in his first interview since his diagnosis became public.
 
 

What cancer patients want and what Medicare covers may differ

 
‎11 ‎September ‎2014, ‏‎04:42:26 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health - When asked what Medicare should cover for cancer patients in their last months of life, many patients and their caregivers choose benefits the federal insurance does not offer, like home-based long term care and concurrent palliative care, according to a new study based on interviews. Given an array of options, a limited budget and a chance to discuss the choices, patients and caregivers were not very likely to devote all coverage to curative cancer treatment, said lead author Donald H. Taylor Jr, of the Sanford School of Public Policy at Duke University in Durham, North Carolina. Medicare covers what it defines as “reasonable and necessary care” and its standards have come to guide what private insurers are willing to pay for as well, Taylor and his colleagues write in the Journal of Clinical Oncology. As Medicare spending is targeted by federal cost cutting, the risk that patient choices will be narrowed increases, they write.
 

Cancer-zapping proton therapy only suitable for rare patients

 
‎11 ‎September ‎2014, ‏‎02:29:17 PMGo to full article
The parents of British five-year-old Ashya King, who has a brain tumor, ignored medical advice, removed him from hospital and left the country at the end of August, saying they wanted to take him to a private clinic in Prague for proton beam therapy - a type of radiotherapy not currently available in Britain. Experts caution, however, that the treatment - a more targeted way of destroying cancerous cells than conventional radiation using photon beams - only offers extra benefits in a small minority of cancer cases. They declined to comment directly on Ashya King's case but said the type of brain cancer he has - medulloblastoma - is not usually suited to proton beam treatment. "Dose for dose, proton beam therapy is actually no more effective on the cancer cells than conventional radiotherapy - so it isn't a magic bullet in that sense," said Adrian Crellin, a consultant clinical oncologist and the government's national clinical lead in proton beam therapy.
 

Ebola highlights slow progress in war on tropical diseases

 
‎11 ‎September ‎2014, ‏‎11:38:48 AMGo to full article
A document is pictured at the opening of a consultation of international experts on potential Ebola therapies and vaccines in GenevaThe worst-ever Ebola outbreak, which has already killed at least 2,296 people in West Africa, has triggered a scramble to develop the first drug or vaccine for a deadly disease that was discovered nearly 40 years ago in the forests of central Africa. The absence of economic incentives for drugmakers to develop and supply medicines for neglected tropical diseases (NTDs) has long been highlighted by health campaigners, but it rarely gets on to the political radar in the West. Out of 336 brand-new drugs approved for all diseases between 2000 and 2011, only four, or 1 percent, were for such conditions - three for malaria and one for diarrhoeal disease, according to a study published in The Lancet journal last year. The Ebola outbreak now ravaging West African communities could change those statistics as biotech firms and pharmaceutical companies, spurred on by government funding, fast-track drug development programs.
 
 

Ebola draws attention to neglected tropical diseases

 
‎11 ‎September ‎2014, ‏‎11:29:56 AMGo to full article
(Reuters) - Ebola is just one of many neglected tropical diseases that badly need attention. Post-exposure prophylactic treatment is possible. TRACHOMA A bacterial eye infection that can cause blindness, affecting more than 40 million people in over 50 countries. YAWS Chronic skin infections, also known as endemic treponematoses, caused by bacteria.
 

Sanofi says MS drug Lemtrada shows sustained effect on disease

 
‎11 ‎September ‎2014, ‏‎07:16:48 AMGo to full article
Sanofi rare disease unit Genzyme said its Lemtrada multiple sclerosis (MS) drug showed continued efficacy for four years in more than two thirds of patients and that no new safety risks had been identified in its latest studies. Approximately 70 percent of patients who received Lemtrada in two courses of treatment over two years did not need to receive further treatment with the drug during the two-year extension study, Genzyme said in a statement on Thursday. Genzyme will detail the results of its latest studies before the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS).
 

U.S. FDA approves expanded use of Medivation prostate cancer drug

 
‎11 ‎September ‎2014, ‏‎12:41:42 AMGo to full article
The expanded Food and Drug Administration approval will also enable the drug to better compete with Johnson & Johnson's Zytiga. The approval triggers $90 million in milestone payments to Medivation by Japan's Astellas under a collaboration agreement.
 

Reflections of a Childhood Cancer Survivor

 
‎10 ‎September ‎2014, ‏‎09:43:22 PMGo to full article
"This isn't forever; this is just a roadblock along the way."My 12-year-old self couldn't have seen it at the time, but the truth of what my nurse said to me when I was diagnosed with stage-IV Hodgkin's Lymphoma would come to reveal itself in its own timely way. It resonates a little more deeply at each roadblock I encounter along the journey...
 

What cancer patients want and what Medicare covers may differ

 
‎10 ‎September ‎2014, ‏‎08:38:11 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) - When asked what Medicare should cover for cancer patients in their last months of life, many patients and their caregivers choose benefits the federal insurance does not offer, like home-based long term care and concurrent palliative care, according to a new study based on interviews. Given an array of options, a limited budget and a chance to discuss the choices, patients and caregivers were not very likely to devote all coverage to curative cancer treatment, said lead author Donald H. Taylor Jr, of the Sanford School of Public Policy at Duke University in Durham, North Carolina. Medicare covers what it defines as “reasonable and necessary care” and its standards have come to guide what private insurers are willing to pay for as well, Taylor and his colleagues write in the Journal of Clinical Oncology. As Medicare spending is targeted by federal cost cutting, the risk that patient choices will be narrowed increases, they write.
 

'No progression' of cancer for British boy Ashya: Czech centre

 
‎10 ‎September ‎2014, ‏‎07:31:14 PMGo to full article
Brett King (L) looks on as his son Ashya arrives at Motol hospital, on September 8, 2014, in PragueScans show "no progression" of cancer for five-year-old British brain tumour patient Ashya King, a Prague medical centre said Wednesday, as he was cleared for potentially life-saving proton treatment there. "We've learnt there's been no progression," Iva Tatounova, marketing director at the Proton Therapy Centre, told AFP.
 
 

Suspected Ebola case in Italy is actually malaria: local government

 
‎10 ‎September ‎2014, ‏‎11:57:21 AMGo to full article
Doctors testing a woman suspected of being infected with Ebola in central Italy have found she is actually suffering from malaria, the regional government said on Wednesday. The woman was hospitalized on Tuesday morning with symptoms suggesting the deadly hemorrhagic fever estimated by the World Health Organization to have killed at least 2,296 people in this year's outbreak, the worst in history. The region of Marche said on its website the patient, a woman who had recently returned to Italy from Nigeria, remained in hospital receiving treatment for malaria, adding it would stay on high alert against the risk of the virus. There have been no cases of Ebola confirmed in Italy.
 

Chronic use of common sedative linked to Alzheimer's risk

 
‎10 ‎September ‎2014, ‏‎01:46:53 AMGo to full article
A woman suffering from Alzheimer's disease holds the hand of a relative on March 18, 2011 in a retirement house in AngervilliersLong-term use of a drug commonly prescribed for anxiety and sleeplessness is linked to a greater risk of Alzheimer's, a study said on Wednesday. Whether chronic use of benzodiazepines actually causes the brain disease is unknown, but the link is so glaring that the question should be probed, its authors said. Researchers in France and Canada, using a health insurance database in Quebec, identified 1,796 people with Alzheimer's whose health had been monitored for at least six years before the disease was diagnosed. They found that patients who had extensively used benzodiazepines for at least three months in the past, were up to 51 percent more likely to be diagnosed with Alzheimer's. The risk rose the longer the patient had used the drug.
 
 

ViaCyte starts diabetes trial

 
‎10 ‎September ‎2014, ‏‎01:16:00 AMGo to full article
ViaCyte starts human testing of a first-ever diabetes treatment derived from stem cells.
 

Cancer patient Ashya King, 5, arrives in Prague for treatment

 
‎09 ‎September ‎2014, ‏‎11:24:44 AMGo to full article
Naghemeh King (centre) stands next to her son Ashya as they arrive at the Motol hospital, on September 8, 2014, in PragueAshya King, the five-year-old cancer patient whose parents sparked an international manhunt after they took him from hospital in Britain, arrived in Prague Monday for potentially life-saving treatment after leaving Spain. "I'm so happy, for one month I've tried to get here and now we've arrived, it's amazing," Ashya's father Brett King told reporters after landing in the Czech capital where his son is scheduled to undergo alternative therapy. Ashya appeared fatigued while attendants loaded him into an ambulance. He underwent surgery for a brain tumour in his native Britain before his parents removed him from hospital and is now being prepared for proton beam therapy in Prague, a treatment that was unavailable to him at home.
 
 

A badger pelt in the bassinet could help reduce baby’s risk for asthma: study

 
‎08 ‎September ‎2014, ‏‎07:53:10 PMGo to full article
A badger pelt in the bassinet could help reduce baby’s risk for asthma: studySleeping on animal fur shortly after birth could protect against allergies and asthma, according to German researchers who presented a large-scale, 16-year cohort study at the European Respiratory Society (ERS) International Congress in Munich Monday. Exposure to the microbial environment of animal fur during the first three months of life could help reduce the chances of developing asthma during childhood, according to Dr. Christina Tischer, from the Helmholtz Zentrum München Research Centre and her team. "Previous studies have suggested that microbes found in rural settings can protect from asthma," says Tischer, referring to studies conducted using data from participants from rural areas. Dr. Tischer and her team set out to explore the question as to whether animal pelts could make up for the lack of exposure to dander and nature common among children born and living in urban settings.
 
 

British boy arrives in Prague for cancer treatment

 
‎08 ‎September ‎2014, ‏‎07:22:17 PMGo to full article
A general view of Motol hospital that gets ready to receive 5-year-old Ashya King for cancer treatment in Prague, Czech Republic, Monday, Sept. 8, 2014. Ashya King who has a severe brain tumor is being readied to travel from southern Spain for treatment in the Czech Republic's capital Prague. (AP Photo/Petr David Josek)PRAGUE (AP) — A British boy who caused an uproar after being taken by his parents from a U.K. hospital without doctors' consent landed in Prague on Monday to get treatment for his brain tumor.
 
 

Evotec takes charge for end of diabetes drug development

 
‎08 ‎September ‎2014, ‏‎06:26:28 PMGo to full article
German biotechnology company Evotec said on Monday it would take an impairment charge of 8.7 million euros ($11.3 million) after one of its advanced projects, diabetes drug Diapep277, was terminated. The trial was terminated by Hyperion Therapeutics, which said on Sunday it would stop developing the drug after discovering manipulation of trial data by employees of a recently acquired subsidiary, Andromeda Biotech. Along with the non-cash impairment, Evotec said it had open receivables of 3.4 million euros outstanding due from Hyperion and Andromeda, which it would need to meet its 2014 profit targets.
 

Parkinson's, cancer findings earn medical prizes

 
‎08 ‎September ‎2014, ‏‎04:34:22 PMGo to full article
This combination of undated photos provided by the The Albert and Mary Lasker Foundation shows Dr. Alim Louis Benabid, of Joseph Fourier University in Grenoble, France, left, and Dr. Mahlon Delong of Emory University in Atlanta. The pair will share the Lasker award for clinical medical research for developing a surgical treatment for Parkinson's disease, the foundation announced Monday, Sept. 8, 2014. (AP Photo/Lasker Foundation)NEW YORK (AP) — Key discoveries about breast cancer, Parkinson's disease and the body's handling of defective proteins have earned prestigious medical awards for five scientists.
 
 

Hyperion stops diabetes drug development, shares fall

 
‎08 ‎September ‎2014, ‏‎03:38:19 PMGo to full article
(Reuters) - Hyperion Therapeutics Inc said it would stop development of a diabetes drug following discovery of unlawful conduct by some employees of a recently acquired subsidiary, sending its shares down 25 percent premarket. The company said some employees of Andromeda Biotech Ltd, which Hyperion acquired in June, engaged in serious misconduct that involved receiving unblinded data from the trial, DIA-AID 1, and manipulating it to obtain a favorable result. Hyperion said additional evidence indicates that the employees of Andromeda, which is based in Israel, continued sharing and examining unblinded data from an ongoing DIA-AID 2 trial.
 

Hyperion stops diabetes drug development

 
‎08 ‎September ‎2014, ‏‎02:23:13 PMGo to full article
(Reuters) - Hyperion Therapeutics Inc said it would stop development of its diabetes drug, after the company discovered that certain employees of its recently acquired subsidiary engaged in unlawful conduct. Employees of the Israeli drug developer, Andromeda Biotech Ltd, which Hyperion acquired in June, engaged in serious misconduct that involved receiving unblinded data from the trial and manipulating it to obtain a favorable result, Hyperion said. (Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila)
 

Roche's rheumatoid arthritis drug wins EU approval for extended use

 
‎08 ‎September ‎2014, ‏‎07:22:05 AMGo to full article
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in BaselSwiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis. Roche said the European Commission has backed RoActemra as a treatment for patients with severe, active and progressive rheumatoid arthritis who have previously not been treated with methotrexate. About 40 million people worldwide are affected by rheumatoid arthritis, a disease that causes joints to become chronically inflamed and swollen. RoActemra is already approved as a treatment for moderate-to-severe rheumatoid arthritis in patients who have failed to respond adequately or are intolerant to previous therapy.
 
 

Isolated Peruvian tribe risks human contact, and disease

 
‎07 ‎September ‎2014, ‏‎05:08:42 PMGo to full article
Machinguenga indigenous prepare for a meeting with government authorities to express their concern about the approach of uncontacted tribes to their village, in ShipetiariBy Mitra Taj ALTO MADRE DE DIOS RIVER Peru (Reuters) - Six Mashco Piro tribeswomen crouched low as they escaped back into the jungle after raiding a remote lodge in Peru's Manu National Park in the western Amazon, clutching newly prized tools: metallic cooking pots. The Mashco Piro have clashed in the past with loggers, poachers and drug traffickers who invaded their jungle enclaves, but anthropologists say the lure of modern tools is now tempting them closer than ever to far-flung villages and tourist camps. "It's a technological revolution," said anthropologist Klaus Rummenhoeller, who has been studying Amazonian tribes in Peru since the 1980s. The Mashco Piro have historically rejected outsiders, surviving enslavement during Peru's bloody rubber boom in the late 1800s and rebuffing the advances of Christian missionaries throughout the last century.
 
 

Depression more common for cancer patients, but rarely treated

 
‎05 ‎September ‎2014, ‏‎10:08:54 PMGo to full article
By Kathryn Doyle NEW YORK (Reuters Health) – Three new studies by researchers at the Universities of Oxford and Edinburgh in the U.K. reveal that three-quarters of depressed cancer patients are not receiving treatment for depression. The researchers also found that serious depression is more common for cancer patients than for the general population, and varies by type of cancer. They also tested a new treatment program, with mental health care integrated into cancer treatment, which was much more effective at reducing depression and improving quality of life than current treatments, they found. Cancer doctors focus on the cancer, but depression deserves attention and treatment too, said Dr. Michael Sharpe of Psychological Medicine Research at the University of Oxford Department of Psychiatry, who co-wrote all three papers.
 

FDA OKs Merck drug, 1st in new cancer drug class

 
‎04 ‎September ‎2014, ‏‎11:41:49 PMGo to full article
FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File)TRENTON, N.J. (AP) — Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments.
 
 

Lilly's diabetes drug trumps Sanofi's in late-stage trials

 
‎04 ‎September ‎2014, ‏‎03:57:04 PMGo to full article
(Reuters) - Eli Lilly and Co said its diabetes drug was more effective than Sanofi SA's approved drug, Lantus, in reducing blood sugar levels in late-stage trials. The drug, basal insulin peglispro, showed improved blood sugar levels, compared with Lantus in patients with type 1 diabetes as well as type 2. Lilly said it was on track to file a submission with the U.S. Lilly's drug is being studied as a once-daily treatment for both type 1 and type 2 diabetes.
 

Pilots, cabin crew 'twice as likely to get skin cancer'

 
‎04 ‎September ‎2014, ‏‎01:25:24 AMGo to full article
A pilot stands outside Lisbon's Airport on August 9, 2014Airline pilots and cabin crew are twice as likely to suffer from skin cancer because of regular exposure to harmful ultraviolet rays from the sun at high altitude, US researchers said in a study published Wednesday. The incidence rate was attributed to ultraviolet rays filtering into planes at high altitude through cockpit windscreens and windows on the fuselage, the study's author said. The research showed that while pilots and flight crew were known to be at risk from ionizing radiation, ultraviolet exposure was not a well-recognized occupational risk.
 
 

Uninformed breast cancer patients more apt to consider removing the other breast, too

 
‎03 ‎September ‎2014, ‏‎11:44:32 PMGo to full article
By Megan Brooks NEW YORK (Reuters Health) – More than half of women newly diagnosed with breast cancer consider removal of the second, unaffected breast to prevent cancer spread, and according to a new survey, they tend to have more anxiety and less knowledge about breast cancer than women who don't consider CPM. “There is so much information about breast cancer that it’s easy for patients to get overwhelmed. Interventions that address patient anxiety and lack of knowledge are needed to facilitate more informed decision making for patients,” Dr. Katharine Yao, director of the breast surgical program at NorthShore University HealthSystem in Evanston, Illinois, said during a press briefing September 2. Previous research has shown that for women with early stage breast cancer who don't have high-risk genes or a family history of the disease, removing the healthy breast doesn't afford much of a survival benefit and may increase complications.
 

Flu shots effective in pregnant women with or without HIV

 
‎03 ‎September ‎2014, ‏‎11:23:19 PMGo to full article
By Gene Emery NEW YORK (Reuters Health) - Tests conducted in 2011 and 2012 show that the influenza vaccine effectively prevents flu infections in pregnant women, whether or not they are infected with HIV. "The findings conform with current practice, which is to give the flu shot to everyone," Dr. Karen Deighan, an obstetrician and gynecologist at the Loyola University Health System in Maywood, Illinois, told Reuters Health. "This study provides greater surety in terms of the benefits of being vaccinated" even when a woman has HIV, chief author Dr. Shabir Madhi of Chris Hani-Baragwanath Hospital in Gauteng, South Africa, said in a telephone interview. The double-blind, randomized, placebo-controlled trials were conducted with 2,237 women in South Africa - 188 of whom had HIV - who were followed with weekly monitoring until 24 weeks after they delivered their child.
 

Airline crews may be more likely to get skin cancer

 
‎03 ‎September ‎2014, ‏‎10:59:31 PMGo to full article
By Andrew M. Seaman NEW YORK (Reuters Health) – Pilots and flight attendants may be at an increased risk of developing the most deadly form of skin cancer, suggests a new analysis. While the study cannot pinpoint why flight crews are at higher risk, the researchers suggest it could be the result of greater exposure to ultraviolet (UV) radiation, which causes damage to the DNA in skin cells, at high altitudes. “This is very worrisome and awareness needs to increase and protective measurements must be undertaken,” said the study’s lead author, Dr. Martina Sanlorenzo from the University of California, San Francisco. Pilots and other members of the cabin crew should be aware of the increased risk, she told Reuters Health in an email.
 

Google's Calico, AbbVie forge deal against diseases of aging

 
‎03 ‎September ‎2014, ‏‎09:31:37 PMGo to full article
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock ExchangeAbbVie and Calico said on Wednesday the initial funding would help Calico use its scientific expertise to create research facilities in the San Francisco Bay area. "Calico expects to begin filling critical positions immediately and plans to establish a substantial team of scientists and research staff in the San Francisco Bay area," the companies said in a joint release.
 
 

Parents Speak Out After Being Jailed for Taking Cancer-Stricken Son Out of Country

 
‎03 ‎September ‎2014, ‏‎07:39:36 PMGo to full article
Parents Speak Out After Being Jailed for Taking Cancer-Stricken Son Out of CountryAshya King's Parents Speak Out After Release From Jail
 
 

Double mastectomy 'doesn't boost cancer survival rates'

 
‎03 ‎September ‎2014, ‏‎10:57:13 AMGo to full article
A growing number of women are choosing to have a double mastectomy after being diagnosed with breast cancerWomen fighting cancer in one breast don't benefit from having both breasts removed, according to new research out Tuesday, that found long-term survival was equivalent after targeted surgery plus radiation. Hollywood star Angelina Jolie famously announced last year she had a double mastectomy to reduce her risk of one day developing breast cancer, because she has a genetic mutation that substantially increases breast cancer risk. It was the first study to directly compare survival rates between the three main surgical interventions used in breast cancer: a single or a double mastectomy, or a lumpectomy to removing only the cancerous tissue, followed by radiation therapy.
 
 

Diabetes walk to be held Sept. 27

 
‎03 ‎September ‎2014, ‏‎07:25:34 AMGo to full article
DIABETES WALK The 21st Step Out: Walk to Stop Diabetes, sponsored by the local chapter of the American Diabetes Association, will be Sept. 27. To register or get more information for the walk, visit www.diabetes.
 

People with widespread pain more likely to develop insomnia

 
‎02 ‎September ‎2014, ‏‎10:58:47 PMGo to full article
The risk of long-term sleep problems was even higher for people reporting widespread pain in the survey. It might not be just the pain that's leading to insomnia, the researchers say. Instead, much of the connection could be explained by lifestyle changes that often happen due to persistent pain, said lead author Nicole K.Y. Tang of the University of Warwick in Coventry, U.K. “Although we know that people with chronic pain are more likely to report problems sleeping than people without any pain, we know very little about how the presence of pain leads to the development of insomnia,” said Tang. Anyone with trouble falling or staying asleep, waking early, and waking up feeling tired and worn out on most nights of the last month were put in the insomnia category.
 

Teva finds positive results in advanced trials for asthma drug

 
‎02 ‎September ‎2014, ‏‎05:02:30 PMGo to full article
Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations - episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness - compared to patients taking a placebo in both Phase III studies, Israel based Teva said on Tuesday. Reslizumab also demonstrated a positive effect on lung function and asthma control, Teva said, noting the data will be presented at the European Respiratory Society Congress next week.
 

Novo Nordisk drops inflammation business to focus on diabetes

 
‎02 ‎September ‎2014, ‏‎03:02:53 PMGo to full article
Insulin jabs are pictured on a production line in Novo Nordisk's plant in KalundborgBy Stine Jacobsen COPENHAGEN (Reuters) - Danish pharmaceutical company Novo Nordisk has stopped research and development activities in inflammatory disorders to concentrate on the prevention and treatment of diabetes, its biggest business. Chief Science Officer Mads Krogsgaard Thomsen said with the setback for anti-IL-20, the earliest possible entrance into the market for anti-inflammatory therapeutics would have been in the late 2020s. Instead, the company aimed to increase its research and development within its core diabetes business. "Significant un-met opportunities remain within diabetes, including prevention, obesity and diabetes complications," Thomsen said in a statement.
 

 

‎16 ‎September ‎2014, ‏‎01:35:13 PM

 

Brain scans used to forecast early reading difficulties

 
‎16 ‎September ‎2014, ‏‎02:28:16 AMGo to full article
Researchers have used brain scans to predict how young children learn to read, giving clinicians a possible tool to spot children with dyslexia and other reading difficulties before they experience reading challenges.
 

3-D printing of rocks and fossils

 
‎16 ‎September ‎2014, ‏‎02:28:14 AMGo to full article
Geologists are using 3-D printing to study the pores within limestone reservoir rocks. A better understanding of the pore networks within the rocks could help industry get at more oil.
 

UT Southwestern one of two institutions to offer innovative four-flap microsurgery approach to breast reconstruction

 
‎16 ‎September ‎2014, ‏‎02:28:10 AMGo to full article
UT Southwestern Medical Center is one of only two places in the world that offers a new, innovative and highly successful approach to breast reconstruction after a mastectomy.
 

Tropical tree microbiome discovered in Panama

 
‎15 ‎September ‎2014, ‏‎10:53:00 PMGo to full article
Despite the fact that tropical forests are the most biodiverse terrestrial ecosystems on the planet, more is known about belly-button bacteria than bacteria on trees in the tropics. Scientists working on Panama's Barro Colorado Island discovered that small leaf samples from a single tree were home to more than 400 different kinds of bacteria. The combined sample from 57 tree species contained more than 7,000 different kinds.
 

EEG study findings reveal how fear is processed in the brain

 
‎15 ‎September ‎2014, ‏‎10:52:58 PMGo to full article
New research illustrates how fear arises in the brain when individuals are exposed to threatening images. This novel study is the first to separate emotion from threat by controlling for the dimension of arousal.
 

Researcher develops, proves effectiveness of new drug for spinal muscular atrophy

 
‎15 ‎September ‎2014, ‏‎10:52:56 PMGo to full article
Approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy (SMA), According to recent studies. This illness is a neurodegenerative disease that causes muscles to weaken over time. Now, researchers have made a recent breakthrough with the development of a new compound found to be highly effective in animal models of the disease.
 

New halogenation enzyme found: Discovery to impact pharmaceutical and agricultural industries

 
‎15 ‎September ‎2014, ‏‎10:52:23 PMGo to full article
One of the Holy Grails in chemical science has been to find the late-stage, site-specific incorporation of a halogen atom into a complex natural product by replacing an sp³ C-H bond -- one of the most inert chemical bonds known in an organic compound -- with a C-X bond, X=halogen.
 

New producer of crucial vitamin B12 discovered

 
‎15 ‎September ‎2014, ‏‎10:52:21 PMGo to full article
A single group of microorganisms may be responsible for much of the world's vitamin B12 production in the oceans, with implications for the global carbon cycle and climate change, researchers have discovered. Thaumarchaeota, they say, are likely dominant vitamin B12 producers.
 

'Squid skin' metamaterials project yields vivid color display

 
‎15 ‎September ‎2014, ‏‎10:52:19 PMGo to full article
The quest to create artificial 'squid skin' -- camouflaging metamaterials that can 'see' colors and automatically blend into the background -- is one step closer to reality, thanks to a breakthrough color-display technology just unveiled.
 

X-rays unlock a protein's SWEET side

 
‎15 ‎September ‎2014, ‏‎10:49:29 PMGo to full article
Understanding just how sugar makes its way into the cell could lead to the design of better drugs for diabetes patients and an increase in the amount of fruits and vegetables farmers are able to grow. Researchers have recently uncovered one of these "pathways” into the cell by piecing together proteins slightly wider than the diameter of a strand of spider silk.
 

Certain form of baldness at age 45 linked to higher risk for aggressive prostate cancer

 
‎15 ‎September ‎2014, ‏‎10:49:23 PMGo to full article
A new, large cohort analysis from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, indicates that men who had moderate baldness affecting both the front and the crown of their head at age 45 were at a 40% increased risk of developing aggressive prostate cancer (usually indicates a faster growing tumor resulting in poorer prognosis relative to non-aggressive prostate cancer) later in life, compared to men with no baldness. There was no significant link between other patterns of baldness and prostate cancer risk.
 

Number-crunching could lead to unethical choices, says new study

 
‎15 ‎September ‎2014, ‏‎09:39:57 PMGo to full article
Calculating the pros and cons of a potential decision is a way of decision-making. But repeated engagement with numbers-focused calculations, especially those involving money, can have unintended negative consequences.
 

Neuroscientists identify key role of language gene

 
‎15 ‎September ‎2014, ‏‎09:39:53 PMGo to full article
Neuroscientists have found that a gene mutation that arose more than half a million years ago may be key to humans' unique ability to produce and understand speech.
 

Researchers control surface tension to manipulate liquid metals

 
‎15 ‎September ‎2014, ‏‎09:39:51 PMGo to full article
Researchers have developed a technique for controlling the surface tension of liquid metals by applying very low voltages, opening the door to a new generation of reconfigurable electronic circuits, antennas and other technologies.
 

'Femme fatale' emerald ash borer decoy lures, kills males

 
‎15 ‎September ‎2014, ‏‎09:38:42 PMGo to full article
An international team of researchers has designed decoys that mimic female emerald ash borer beetles and successfully entice male emerald ash borers to land on them in an attempt to mate, only to be electrocuted and killed by high-voltage current. "Our new decoy and electrocution process may be useful in managing what the U.S. Department of Agriculture Forest Service claims to be the most destructive forest pest ever seen in North America," said one expert.
 

Concussions: 'Hidden injury' in sports

 
‎15 ‎September ‎2014, ‏‎09:38:40 PMGo to full article
Two new studies shed light on the most common form of head injury seen in athletes. They suggest that concussions continue to be a 'hidden injury' in sports, even in the face significant increased public awareness.
 

Combining Epilepsy Drug, Morphine Can Result in Less Pain, Lower Opioid Doses

 
‎15 ‎September ‎2014, ‏‎09:36:13 PMGo to full article
Adding a common epilepsy drug to a morphine regimen can result in better pain control, fewer side effects and reduced morphine dosage, according to research. The result could bring significant relief to many patients with neuropathic pain, a difficult-to-treat condition often felt in the arms and legs and associated with nerve tissue damage.
 

Elusive quantum transformations found near absolute zero

 
‎15 ‎September ‎2014, ‏‎09:36:11 PMGo to full article
To isolate quantum fluctuations that define the properties of a metallic material, scientists probed it at temperatures colder than interstellar space. The research provides new methods to identify and understand promising new materials, including superconductors.
 

Slow to mature, quick to distract: ADHD brain study finds slower development of key connections

 
‎15 ‎September ‎2014, ‏‎09:36:07 PMGo to full article
A peek inside the brains of more than 750 children and teens reveals a key difference in brain architecture between those with attention deficit hyperactivity disorder and those without. Kids and teens with ADHD, a new study finds, lag behind others of the same age in how quickly their brains form connections within, and between, key brain networks.
 

Decoding virus-host interactions in the oxygen-starved ocean

 
‎15 ‎September ‎2014, ‏‎08:09:40 PMGo to full article
In certain coastal areas, severe reductions in oxygen levels in the water destroy food web structure. Over the past 50 years, such oxygen minimum zones have expanded due to climate change and increased waste run-off. Researchers studied how viral infection influences a microbial community in one such OMZ.
 

In wake of uproar over Facebook’s emotional manipulation study, bioethics scholars say new rules are 'moral imperative'

 
‎15 ‎September ‎2014, ‏‎08:09:13 PMGo to full article
Using the recent debate over the Facebook-Cornell "emotional contagion" study as a starting point, an international team of research ethics scholars begin mapping the ethics terrain of large-scale social computing research in a new article.
 

Early Earth less 'Hellish' than previously thought

 
‎15 ‎September ‎2014, ‏‎08:09:11 PMGo to full article
Conditions on Earth during its first 500 million years may have been cool enough to form oceans of water instead of being too hot for life to form. This alternate view of Earth's first geologic eon, called the Hadean, has gained substantial new support from the first detailed comparison of zircon crystals that formed more than 4 billion years ago with those formed contemporaneously in Iceland, which has been proposed as a possible geological analog for early Earth.
 

Novel method for working with nanotubes

 
‎15 ‎September ‎2014, ‏‎07:29:47 PMGo to full article
Researchers have developed a novel method for controllably constructing precise inter-nanotube junctions and a variety of nanocarbon structures in carbon nanotube arrays. The researchers were able to tailor the physical properties of nanotube networks for use in applications from electronic devices to carbon nanotube-reinforced composite materials found in cars and sports equipment.
 

Long-term effects of childhood asthma influenced by socioeconomic status

 
‎15 ‎September ‎2014, ‏‎07:29:45 PMGo to full article
Asthma is associated with attention and behavioral issues in children, yet little existing research examines how socioeconomic status may influence the ultimate effects of these difficulties. Now, a researcher has found that the overall outcomes for children with asthma are influenced by socioeconomic inequalities.
 

Report urges individualized, cholesterol-targeted approach to heart disease, stroke

 
‎15 ‎September ‎2014, ‏‎07:29:43 PMGo to full article
A recent guideline for using statins to reduce atherosclerotic cardiovascular disease has wavered too far from the simple cholesterol goals that have saved thousands of lives in the past decade, and doesn't adequately treat patients as individuals, experts say.
 

Small algae with great potential

 
‎15 ‎September ‎2014, ‏‎07:29:41 PMGo to full article
The single most important calcifying algae of the world's oceans is able to simultaneously adapt to rising water temperatures and ocean acidification through evolution. A unique long-term experiment with the species Emiliania huxleyi shows that the evolutionary potential of the algae is much greater than previously thought. In their laboratory evolution experiment, the scientists have shown for the first time that evolutionary adaptations to multiple stress factors do not necessarily interfere with each other.
 

Strategic self-sabotage? MRSA inhibits its own growth

 
‎15 ‎September ‎2014, ‏‎07:29:39 PMGo to full article
A bacterial mystery has finally been uncovered. Against all logic, the most predominant strain of methicillin-resistant Staphylococcus aureus (MRSA) in North American produces an enzyme that degrades skin secretions into compounds that are toxic to itself.
 

Care coordination can decrease health-care use by frequent users

 
‎15 ‎September ‎2014, ‏‎07:29:34 PMGo to full article
Better coordination of patient care between health care providers, encouraging patients to self-manage their health and other strategies can reduce use of the health care system by seniors and people with chronic conditions, according to research.
 

When rulers can't understand the ruled: Study finds significant gaps between Washington insiders, general Americans

 
‎15 ‎September ‎2014, ‏‎07:28:18 PMGo to full article
A significant gap has been found in demographics, experience and partisanship between Washington insiders and the Americans they govern. "The elements of difference we have identified between the rulers and the ruled give us some reason to suspect that the two groups may not perceive the political world in the same way," the researchers write. "Taken together, these elements could well create a substantial cognitive and perceptual gulf between official and quasi-official Washington on the one hand and the American public on the other."
 

Delay in age of walking can herald muscular dystrophy in boys with cognitive delays

 
‎15 ‎September ‎2014, ‏‎06:08:47 PMGo to full article
The timing of a toddler's first steps is an important developmental milestone, but a slight delay in walking is typically not a cause of concern by itself. Now a duo of researchers has found that when walking and cognitive delays occur in concert, the combination could comprise the earliest of signals heralding a rare but devastating disorder known as Duchenne muscular dystrophy.
 

Habitual Facebook users: Suckers for social media scams?

 
‎15 ‎September ‎2014, ‏‎06:08:41 PMGo to full article
A new study finds that habitual use of Facebook makes individuals susceptible to social media phishing attacks by criminals, likely because they automatically respond to requests without considering how they are connected with those sending the requests, how long they have known them, or who else is connected with them.
 

Like my body odor, like my politics: People are attracted to the body odor of others with similar political beliefs

 
‎15 ‎September ‎2014, ‏‎06:08:05 PMGo to full article
A new study reveals that people find the smell of others with similar political opinions to be attractive, suggesting that one of the reasons why so many spouses share similar political views is because they were initially and subconsciously attracted to each other's body odor.
 

Cost-share programs encourage most to mitigate wildfire danger

 
‎15 ‎September ‎2014, ‏‎06:08:03 PMGo to full article
Most homeowners are willing to take part in cost-sharing that helps pay for wildfire risk mitigation on their properties, but some of those with the highest wildfire risk are the least likely to participate in those programs, according to a study.
 

If hippopotamuses can't swim, how can some be living on islands?

 
‎15 ‎September ‎2014, ‏‎06:07:57 PMGo to full article
There is no published account where hippopotamuses are demonstrably shown swimming or floating at the surface of any body of water. But if they can't swim, how did they reach and colonize islands?
 

When casualties increased, war coverage became more negative

 
‎15 ‎September ‎2014, ‏‎06:07:55 PMGo to full article
As the number of U.S. casualties rose in Afghanistan, reporters filed more stories about the conflict and those articles grew increasingly negative about both the war effort and the military, according to a researcher.
 

Caregivers of family members newly diagnosed with mental illness at risk for anxiety

 
‎15 ‎September ‎2014, ‏‎06:07:51 PMGo to full article
Researchers who studied the emotional distress of caring for a family member diagnosed with a mental illness, found anxiety is high for the primary caregiver at the initial diagnosis or early in the course of the illness, and decreases over time.
 

A thin line lies between fantasy and reality in people with psychopathic traits

 
‎15 ‎September ‎2014, ‏‎05:45:36 PMGo to full article
New research indicates that people with psychopathic traits have a preference for nonromantic sexual fantasies with anonymous and uncommitted partners. The study's investigators noted that psychopathic sexual behavior is likely due to a preference for sexual activity outside a loving, committed relationship rather than only an inability to form such relationships.
 

Largest ever study of awareness during general anesthesia identifies risk factors and consequences

 
‎15 ‎September ‎2014, ‏‎05:45:34 PMGo to full article
Accidental awareness is one of the most feared complications of general anesthesia for both patients and anesthetists. Patients report this failure of general anesthesia in approximately 1 in every 19,000 cases, according to a new report. Known as accidental awareness during general anesthesia, it occurs when general anesthesia is intended but the patient remains conscious. This incidence of patient reports of awareness is much lower than previous estimates of awareness, which were as high as 1 in 600.
 

How a change in slope affects lava flows

 
‎15 ‎September ‎2014, ‏‎05:45:26 PMGo to full article
As soon as lava flows from a volcano, exposure to air and wind causes it to start to cool and harden. Rather than hardening evenly, the energy exchange tends to take place primarily at the surface.
 

Run, cheetah, run: New algorithm enables cheetah robot to run and jump, untethered, across grass

 
‎15 ‎September ‎2014, ‏‎05:45:24 PMGo to full article
Speed and agility are hallmarks of the cheetah: The big predator is the fastest land animal on Earth, able to accelerate to 60 mph in just a few seconds. As it ramps up to top speed, a cheetah pumps its legs in tandem, bounding until it reaches a full gallop.
 

Tigers, pandas and people: Recipe for conservation insight

 
‎15 ‎September ‎2014, ‏‎05:45:22 PMGo to full article
The first big revelation in conservation sciences was that studying the people on the scene as well as nature conservation was crucial. Now, as this science matures, researchers are showing that it's useful to compare apples and oranges. Or, more accurately, tigers and pandas. Scientists show that useful insights and ways of scrutinizing wildlife and their habitat can be found in unlikely places.
 

Protein secrets of Ebola virus

 
‎15 ‎September ‎2014, ‏‎05:44:38 PMGo to full article
The current Ebola virus outbreak in West Africa, which has claimed more than 2000 lives, has highlighted the need for a deeper understanding of the molecular biology of the virus that could be critical in the development of vaccines or antiviral drugs to treat or prevent Ebola hemorrhagic fever.
 

Zebrafish genes linked to human respiratory diseases

 
‎15 ‎September ‎2014, ‏‎05:44:36 PMGo to full article
Hundreds of novel genes in the zebrafish have been identified that could be functionally identical to the human genes required for forming motile cilia, hair-like structures on the surface of airway cells. These are required for removing dust and pathogens from the human airway. The study showed that the loss of these genes is linked to development of defective motile cilia, which could be the cause of some respiratory diseases.
 

Creation of the Vuoksi River preceded a significant cultural shift

 
‎15 ‎September ‎2014, ‏‎05:44:28 PMGo to full article
The creation of the Vuoksi River and the subsequent rapid decrease in the water level of Lake Saimaa approximately 6,000 years ago revealed thousands of square kilometers of new, fertile land in eastern Finland. Researchers have studied the role that the decrease in water levels has played in the interaction between nature and humans.
 

New way to predict hurricane strength, destruction

 
‎15 ‎September ‎2014, ‏‎05:42:45 PMGo to full article
A new study demonstrates a different way of projecting a hurricane’s strength and intensity that could give the public a better idea of a storm’s potential for destruction.
 

This is your brain on snacks: Brain stimulation affects craving, consumption

 
‎15 ‎September ‎2014, ‏‎05:42:41 PMGo to full article
Magnetic stimulation of a brain area involved in "executive function" affects cravings for and consumption of calorie-dense snack foods, reports a study. After stimulation of the dorsolateral prefrontal cortex (DLPFC), young women experience increased cravings for high-calorie snacks -- and eat more of those foods when given the opportunity, according to the researchers.
 

Good home care by nurses prevents hospital, nursing home admissions

 
‎15 ‎September ‎2014, ‏‎05:42:39 PMGo to full article
In the largest study of its kind, an investigation shows that home health agencies providing organizational support to their nurses get better outcomes. The best outcomes for patients, including fewest hospitalizations and transfers to nursing homes, are achieved by home health agencies that provide supportive work environments, enabling nurses to focus on patient care.
 

Prostate cancer patients who receive hypofractionated radiation therapy report consistent quality of life before and after treatment

 
‎15 ‎September ‎2014, ‏‎05:42:35 PMGo to full article
Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function were at similar levels before and after RT, according to new research.
 

For racially diverse patients with disabilities, increased barriers to health care

 
‎15 ‎September ‎2014, ‏‎05:42:33 PMGo to full article
It's well established that Americans with disabilities and those in underserved racial/ethnic groups face significant disparities in access to health care. Now, researchers are beginning to examine the unique patterns of health care inequalities experienced by racially and ethnically diverse patients with disabilities.
 

Everyday discrimination impacts mental health

 
‎15 ‎September ‎2014, ‏‎04:21:19 PMGo to full article
Researchers have determined that African Americans and Caribbean blacks who experience discrimination of multiple types are at substantially greater risk for a variety of mental disorders including anxiety, depression and substance abuse.
 

Scientists come closer to the industrial synthesis of a material harder than diamond

 
‎15 ‎September ‎2014, ‏‎04:21:17 PMGo to full article
Researchers have developed a new method for the synthesis of an ultrahard material that exceeds diamond in hardness. The material is an ultrahard fullerite, a polymer composed of fullerenes, or spherical molecules made of carbon atoms.
 

Nurses need education on advance health care directives

 
‎15 ‎September ‎2014, ‏‎04:21:15 PMGo to full article
An educational program for nurses can help address knowledge gaps related to advance health care directives -- thus helping to ensure that patients' wishes for care at the end of life are known and respected, report researchers.
 

The science behind swimming: From whales to larvae, common principles at work in swimming

 
‎15 ‎September ‎2014, ‏‎04:21:13 PMGo to full article
Using simple hydrodynamics, a team of researchers was able to show that a handful of principles govern how virtually every animal -- from the tiniest fish to birds to gigantic whales propel themselves though the water.
 

Skin cancer risks higher for soldiers serving abroad

 
‎15 ‎September ‎2014, ‏‎04:19:53 PMGo to full article
Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer. "This study demonstrates room for improvement for skin cancer prevention and early detection in the military population, including possible screening of higher-risk personnel," a researcher said.
 

Genetics reveals patients susceptible to drug-induced pancreatitis

 
‎15 ‎September ‎2014, ‏‎03:58:59 PMGo to full article
It has long been recognized that about four per cent of patients who are prescribed particular drugs for IBD go on to develop pancreatitis, an inflammation of the pancreas, which can be fatal. Now researchers have found that 17 percent of patients who have two copies of a particular genetic marker are likely to go on to develop pancreatitis if they are prescribed thiopurine drugs.
 

Rolling 'neat' nanotube fibers: Acid-free approach leads to strong conductive carbon threads

 
‎15 ‎September ‎2014, ‏‎03:58:55 PMGo to full article
The very idea of fibers made of carbon nanotubes is neat, but scientists are making them neat -- literally. The single-walled carbon nanotubes in new fibers line up like a fistful of uncooked spaghetti through a new process.
 

Young women involve parent in abortion when anticipating support

 
‎15 ‎September ‎2014, ‏‎03:58:53 PMGo to full article
Pregnant teens will turn to parents and adults who are engaged in their lives and who will offer support, regardless of her pregnancy decision. Young women will avoid talking with parents who are less involved or may try to prevent them from seeking care, a study concludes.
 

Fracking: Gas leaks from faulty wells linked to contamination in some groundwater

 
‎15 ‎September ‎2014, ‏‎03:58:51 PMGo to full article
A study has pinpointed the likely source of most natural gas contamination in drinking-water wells associated with hydraulic fracturing, and it's not the source many people may have feared.
 

Improved survival shown in early-stage Hodgkin's disease patients who receive radiation therapy

 
‎15 ‎September ‎2014, ‏‎03:56:34 PMGo to full article
Patients with stage I and II Hodgkin’s Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to new research.
 

Five radiation oncology treatments to question

 
‎15 ‎September ‎2014, ‏‎03:56:32 PMGo to full article
The American Society for Radiation Oncology has released its second list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate.
 
 
 

 

Weathering the Coming Storm


 

 

 

Price R399.00

 

 


 

Description

Dr. Chuck Missler, an internationally known business executive, outlines our current economic predicament and defensive steps you can take to lessen the impact of the impending economic crisis. As a Bible teacher for over 30 years with a ministry reaching over 40 countries, Chuck shares some key strategies to prepare yourself spiritually and practically.

Is the World facing another major economic upheaval?

What is the best strategy to protect your family in times of economic uncertainty?

The Church has enjoyed a relatively peaceful existence in the West for a few centuries but the with the coming persecution, how do we go about organizing home study and home-church?

Soul Survival – Keeping your “lamp full” during the hard times ahead.

Join Dr. Chuck Missler and Ron Matsen in the Executive Brie fing Room of
The River Lodge, New Zealand, in an intensive summary outlining what lies
ahead and how we can prepare for the coming storm.

Runtime: Approx. 5 hours

© 2012 Koinonia House Inc.

Available in the following formats:

 

DVD:

•3 Disks
•5 M4A Files
•1 PDF Notes File
•Color, 16:9, Dolby Digital 2.0 stereo, Region encoding (This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 

*** New Release ***

Expectations

 of the

 Antichrist

 

 

Dr. Chuck Missler and Ron Matsen

 

Price R 499.00

 

There are many diverse anticipations concerning the Coming World Leader, commonly referred to as “The Antichrist.” This study will explore the Biblical descriptions with the specific expectations of the globalists, Islam, the Vatican, Freemasonry, and others.
• Will he be a Nephilim?
• Why is the Vatican openly preparing to receive an “alien” visitor?
• Will he be a resurrection of Nimrod? Is his DNA a factor?
• What are the expectations of transhumanist technologists in this regard?
Clearly, the Bible has much more to illuminate this issue far beyond the popular conceptions; and yet the composite perspective will astonish most. Furthermore, is there a climactic cosmic deception being prepared that, if it were possible, “it would deceive the very elect”? Jesus commanded us, “Be not deceived.” But, how?
How close are these events to our current horizon?
Join Dr. Chuck Missler and Ron Matsen in an intensive summary of some of the Strategic Trends that will impact all of us.
Available in the following formats:

DVD:
•3 Discs
•6 M4A Files
•1 PDF Notes File
•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  encoding ( This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 

 

 

Feed image

Featured Video

End the Shame. End the Isolation. End Fistula.

 

 

 

 

***Brand New Release***

 

Beginning of Wisdom

by

 Dr. Chuck Missler


“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.
 

Price R 179

 
 

 

Hal Lindsey Report:

 

THE REAL ISSUE

SAME SEX MARRIAGE

 

Genetically Modified Food & People.

 

 

 

Go Live           Link

 

*** New Release ***

 Angels, Volume III:

The Denizens of the Metacosm

 

DVD

 

 

Price R 179.00

 

Angels, Volume III: The Denizens of the Metacosm

 

DVD

by Dr. Chuck Missler

 

Description

Volumes 1 & 2 of this series explored the finite limits and boundaries of our physical reality. After probing the limits of both the Macrocosm and the Microcosm, we discovered that our reality is but a shadow of larger reality, the Metacosm, a domain of extra-dimensional transfers and other paradoxical phenomena.

 

Volume 3 explores the contradictory behavior of UFOs and other demonic deceptions characteristic of the End Times. Explore these topics in more detail in either this two-hour briefing, Angels Vol 3: The Denizens of the Metacosm or our six-hour extensive study, Expectations of the Antichrist.

 

 

• Are they real?

• Why do UFOs enjoy a military classification higher than our most sensitive weapons systems?

• Why are the events which occurred in Roswell New Mexico still classified after 66 years?

• Why is the Vatican openly preparing to receive an Alien Visitor?

• How should a Christian deal with the occurrences of Alien abductions?

• Jesus admonished us to “Be not deceived.” How?

• How do we prepare for the deception which, “if it were possible, would deceive the very elect”?

 

Join Dr. Chuck Missler in the Executive Briefing Room of the River Lodge, New Zealand, exploring the misinformation, (and deliberate disinformation) about the various “denizens of the Metacosm” and other insights of the invisible war unfolding on our near horizon.

 

This briefing pack contains 2 hours of teaching

 

Available in the following formats

 

DVD:

•1 Disc

•2 M4A Files

•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region. This DVD will be viewable in other countries WITH the proper DVD player and television set.)

 

DVD

PRICE  R 159.00

DVD

PRICE R 159.00

 

DVD

Price  R 159.00

 

DVD

Price R 159.00

 

 

 

 

 

 

 

 

 

 

 

 


Global Events Disaster Site


Extreme Weather, Epidemic, Terror Attack, Biological Hazard,

Volcano Eruption, Earthquake, Incidents at Sea

 

 

"In seasons of severe trial, the Christian has nothing on earth that he can trust to, and is therefore compelled to cast himself on God alone. When no human deliverance can avail, he must simply and entirely trust himself to the providence and care of God. Happy storm that wrecks a man on such a rock as this! O blessed hurricane that drives the soul to God--and God alone!"
- Spurgeon

 

 

 

***SPECIAL OFFER ***

The Hybrid Age  

BUY THE DVD

&

GET THE BOOK

 

ONLY

PRICE R199.00

THIS LINK ONLY

 

 

The Hybrid Age  


by Tom Horn and Chuck Missler

 
 
 
Price R 159.00
 
 

***In Stock ***

Forbidden Gates: How Genetics, Robotics, Artificial Intelligence, Synthetic Biology, Nanotechnology, and Human Enhancement Herald The Dawn Of TechnoDimensional Spiritual Warfare.
THE BOOK

 

Price R179.00

 

 

Book

While Forbidden Gates includes fresh insights for traditional, tried and true methods of overcoming darkness, it also unveils for the first time how breakthrough advances in science, technology, and philosophy—including cybernetics, bio-engineering, nanotechnology, machine intelligence, synthetic biology, and transhumanism—will combine to create mind-boggling game-changes to everything you have ever known about spiritual warfare.

In recent years, astonishing technological developments have pushed the frontiers of humanity toward far-reaching morphological transformation that promises in the very near future to redefine what it means to be human. An international, intellectual and fast-growing cultural movement known as transhumanism intends the use of genetics, robotics, artificial intelligence and nanotechnology (GRIN technologies) as tools that will radically redesign our minds, our memories, our physiology, our offspring, and even perhaps, as Joel Garreau in his bestselling book Radical Evolution claims, our very souls. The technological, cultural, and metaphysical shift now under way unapologetically forecasts a future dominated by this new species of unrecognizably superior humans, and applications under study now to make this dream reality are being funded by thousands of government and private research facilities around the world. As the reader will learn, this includes among other things rewriting human DNA and combining men with beasts, a fact that some university studies and transhumanists believe will not only alter our bodies and souls but could ultimately open a door to contact with unseen intelligence.

As a result, new modes of perception between things visible and invisible are expected to challenge the Church in ways that are historically and theologically unprecedented. Without comprehending what is quickly approaching in related disciplines of research and development, vast numbers of believers could be paralyzed by the most fantastic—and most far reaching—supernatural implications. The destiny of each individual—as well as the future of their family—will depend on their knowledge of the new paradigm and their preparedness to face it head on.

303 Pages


 

 

 

 

 

+27 11 969 0086


frosty@khouseafrica.com   

 

 

 

 

 

 

 

 

 

 

 

 

 


Bible

DVD

+

MP3 on CD-ROM
Featured Commentaries

Learn the Bible

 in 24 hours



Old Testament


Genesis

Exodus

Leviticus

Numbers

Deuteronomy

Joshua and The Twelve Tribes

Judges

Ruth and Esther

I and II Samuel

I and II Kings

I and II Chronicles

Ezra & Nehemiah

Job

Psalms

Proverbs

Ecclesiastes

Song of Songs

Isaiah

Jeremiah

/Lamentations

Ezekiel

Daniel

Hosea

Joel and Amos

Jonah, Nahum & Obadiah

Micah

Zechariah

The Minor

Prophets

 



New Testament


Matthew

Mark

Luke

John

Acts

Romans

I & II Corinthians

Galatians

Ephesians

Philippians

Colossians and Philemon

I and II

Thessalonians

Timothy/

Titus/Philemon

Hebrews

James

I and II Peter

I, II, and III John

Jude

Revelation

 


 

 

 

 

                                   2